Home LiteratureArticle Details
PMID: 8946433 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.

Chambers RA, Moore J, McEvoy JP, Levin ED

Abstract

Lesioning the ventral hippocampus of neonatal rats has been proposed as an experimental model of schizophrenia. This lesion causes a syndrome of hyperresponsivity to the stimulant effects of amphetamine, impaired grooming and disrupted social interactions, effects that emerge during adolescence, much like schizophrenia. Persisting cognitive effects of neonatal ventral hippocampal lesions were assessed in the current study, because the hippocampus is critically important for a variety of cognitive functions and cognitive impairment and because it is an important feature of schizophrenia. Spatial learning and working memory were assessed in the radial-arm maze, which is sensitive to the adverse effects of hippocampal lesions made in adults. Lesioned rats showed pronounced deficits in radial-arm maze choice accuracy that persisted throughout training. Deficits were seen during the prepubertal period as well as in adulthood. Even though the lesioned rats performed more poorly, they were significantly less sensitive to the amnestic effects of the nicotinic antagonist mecamylamine and the muscarinic antagonist scopolamine. No significant effects of nicotine or amphetamine were seen in either the lesioned or control groups. The long-lasting deficits in spatial learning and working memory resulting from neonatal ventral hippocampal lesions show that, unlike frontal cortical lesions during the same age, the effects of hippocampal lesions are not overcome during development. The resistance to the amnestic effects of nicotinic and muscarinic acetylcholine (ACh) antagonists suggests that the hippocampus is a critical site for the action of these drugs. Neonatal hippocampal lesions may provide a good model of the cognitive impairments of schizophrenia and may be useful to assess novel drug effects to counteract the cognitive deficits in schizophrenia.

MeSH Terms
Amphetamine/pharmacology Animals Behavior, Animal/drug effects Brain Diseases/chemically induced,psychology Central Nervous System Stimulants/pharmacology Disease Models, Animal Female Hippocampus/pathology Ibotenic Acid Male Maze Learning/drug effects Mecamylamine/pharmacology Memory/drug effects Muscarinic Antagonists/pharmacology Nicotine/pharmacology Nicotinic Agonists/pharmacology Nicotinic Antagonists/pharmacology Random Allocation Rats Rats, Sprague-Dawley Schizophrenia/pathology Schizophrenic Psychology Scopolamine/pharmacology
Chemicals
Central Nervous System Stimulants Muscarinic Antagonists Nicotinic Agonists Nicotinic Antagonists Ibotenic Acid Mecamylamine Nicotine Amphetamine Scopolamine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Chambers R A
Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA.
Moore J
McEvoy J P
Levin E D
Article Info
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Abbr.
Neuropsychopharmacology
ISSN
0893-133X
Published
1996-12-00
Pages
587-94
Language
English
Region
England
NLM ID
8904907
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]